Awaiting committee decision
Next event: Vote in committee, 1st reading/single reading 2015/03/23 more...
- Indicative plenary sitting date, 1st reading/single reading 2015/04/28
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | CZARNECKI Ryszard (ECR) | ZDECHOVSKÝ Tomáš (EPP), VAUGHAN Derek (S&D), ALIOT Louis (NI), DE JONG Dennis (GUE/NGL), VALLI Marco (EFD) |
Opinion | ENVI | LA VIA Giovanni (EPP) |
Activites
-
2015/04/28
Indicative plenary sitting date, 1st reading/single reading
-
2015/03/23
Vote in committee, 1st reading/single reading
-
2014/10/20
Committee referral announced in Parliament, 1st reading/single reading
-
2014/07/30
Non-legislative basic document published
-
COM(2014)0510
summary
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2013, as part of the 2013 discharge procedure. Analysis of the accounts of the European Medicines Agency (EMEA). CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2013 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the European Medicines Agency (EMEA). The document contains the figures on which the discharge procedure is based. Discharge procedure of the EU agencies: the EU Budget finances a wide range of policies and programmes throughout the EU. In accordance with the priorities set by the European Parliament and the Council in the multi-annual financial framework (MFF), the European Commission carries out specific programmes, activities and projects in the field with the technical support of some specialised agencies. The consolidated annual accounts of the EU provide information on the activities of the institutions, agencies and other bodies of the EU from a budgetary and accrual accounting perspective. The consolidated reports on the implementation of the general budget of the EU include the budget implementation of all Institutions. Agencies do not have a separate budget inside the EU budget; and they are partially financed by a Commission budget subsidy. Each agency is subject to its own discharge procedure. EMEA: in 2013, the tasks and budget of this agency were as follows: description of the Agency's tasks: the European Medicines Agency, which is located in London, was created by Council Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council and its role is the coordination of the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use on the basis of a centralised procedure; the Agency's budget for the 2013 financial year: the Agency’s budget for 2013, as presented in the Commission document on the consolidated annual accounts of the European Union, gives the following figures: § Commitment appropriations: - committed : EUR 252 million; - paid : EUR 243 million; - carried over : 0. § Payment appropriations: - committed : EUR 292 million; - paid : EUR 249 million; - carried over : EUR 33 million. See also the final accounts of the EMA.
- DG {'url': 'http://ec.europa.eu/dgs/budget/', 'title': 'Budget'}, GEORGIEVA Kristalina
-
COM(2014)0510
summary
Documents
- Non-legislative basic document published: COM(2014)0510
Amendments | Dossier |
3 |
2014/2102(DEC)
2014/12/12
ENVI
3 amendments...
Amendment 1 #
Draft opinion Paragraph 2 2. Notes that in 2013, out of the total resources available to the Agency of EUR 251 560 000, 16,3% (EUR 40 937 454) had been EU budget contributions (including an important and essential special contribution for orphan medicines fee reductions of EUR 6 509 360); likes to stress that this amount represents 0.027% of the overall EU budget;
Amendment 2 #
Draft opinion Paragraph 3 a (new) 3a. Welcomes that a new procedure entered into force in 2014 which corrected the former irregular practice, whereby the Agency paid education contributions directly to schools for staff, in contravention of the Staff Regulations;
Amendment 3 #
Draft opinion Paragraph 4 4. Reiterates the important role of the Agency in protecting and promoting public and animal health by assessing and supervising medicines for human or veterinary use; welcomes the annual declarations and the policy on the handling of conflict of interests, last updated and endorsed by the Management Board in March 2012, and invites the Agency to further strengthen its policy on the management and handling of conflicts of interests in order to ensure independence and transparency in all work areas of the Agency;
source: 544.370
|
History
(these mark the time of scraping, not the official date of the change)
activities/2 |
|
activities/0 |
|
activities/0/body |
Old
EPNew
EC |
activities/0/commission |
|
activities/0/date |
Old
2015-03-23T00:00:00New
2014-07-30T00:00:00 |
activities/0/docs |
|
activities/0/type |
Old
Vote scheduled in committee, 1st reading/single readingNew
Non-legislative basic document published |
activities/0/docs/0/celexid |
CELEX:52014DC0510:EN
|
activities/2/date |
Old
2015-03-24T00:00:00New
2015-03-23T00:00:00 |
activities/0/docs/0/celexid |
CELEX:52014DC0510:EN
|
activities/0/commission/0 |
|
other/0 |
|
activities/1/committees/0/shadows/2/mepref |
Old
545fbdc8d1d1c57505000000New
4f1ac952b819f25efd00012c |
committees/0/shadows/2/mepref |
Old
545fbdc8d1d1c57505000000New
4f1ac952b819f25efd00012c |
activities/0/docs/0/text |
|
activities/1/committees/0/shadows |
|
activities/1/committees/1/date |
2014-11-05T00:00:00
|
activities/1/committees/1/rapporteur |
|
committees/0/shadows |
|
committees/1/date |
2014-11-05T00:00:00
|
committees/1/rapporteur |
|
activities |
|
committees |
|
links |
|
other |
|
procedure |
|